Sinanidis I, Hochman MJ, Tsai HL, Randall MP, et al. Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone Marrow Transplant 2024 May 7. doi: 10.1038/s41409-024-02299.
PMID: 38714755